A detailed history of Jones Financial Companies Lllp transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Jones Financial Companies Lllp holds 2,161 shares of DVAX stock, worth $22,474. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,161
Previous 2,161 -0.0%
Holding current value
$22,474
Previous $28,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 28, 2025

BUY
$12.39 - $14.4 $11,919 - $13,852
962 Added 80.23%
2,161 $28,000
Q1 2025

May 16, 2025

BUY
$12.39 - $14.4 $6,975 - $8,107
563 Added 88.52%
1,199 $15,000
Q2 2024

Aug 14, 2024

BUY
$10.73 - $12.58 $6,824 - $8,000
636 New
636 $7,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.32B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Jones Financial Companies Lllp Portfolio

Follow Jones Financial Companies Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jones Financial Companies Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Jones Financial Companies Lllp with notifications on news.